Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
The Journal of Pharmacy and Pharmacology|January 1, 1996
Oral cavity absorption of (R)-8-hydroxy-2-(di-n-propylamino)tetralin and (S)-8-acetyl-2-(di-n-propylamino)tetralin in the ratH Yu, Y Liu, U Hacksell, et al.Clinical Genetics|May 1, 1981
Dopamine metabolism in red blood cells in schizophreniaT Lewander, G von Pongracz, M Bäckström, et al.European Journal of Pharmacology|May 21, 1982
The pharmacological assessment of a new, potent oxotremorine analogue in mice and ratsB Resul, T Lewander, B Ringdahl, et al.Psychopharmacology|January 1, 1989
Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatmentJ Luthman, A Fredriksson, T Lewander, et al.Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Biochemical pharmacology of the atypical neuroleptic remoxiprideC Köhler, H Hall, O Magnusson, et al.Journal of Medicinal Chemistry|January 6, 1995
Derivatives of cis-2-amino-8-hydroxy-1-methyltetralin: mixed 5-HT1A-receptor agonists and dopamine D2-receptor antagonistsY Liu, H Yu, N Mohell, et al.European Journal of Pharmacology|May 15, 1996
Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralinH Yu, Y Liu, A Malmberg, et al.The Journal of Pharmacy and Pharmacology|September 1, 1981
Thermic and tremorogenic effects of thyroliberin (TRH) in reserpine-treated mice--the non-involvement of GABA-ergic mechanismsS Björkman, T Lewander, J A Karlsson, et al.L'Encephale|March 1, 1990
[Remoxipride, a selective antagonist of dopamine D2 receptors, in the treatment of delusional psychoses]T Lewander, S E Westerberg, S O Ogren, et al.Pharmacogenomics|March 22, 2001
Pharmacogenomics to predict drug responseG I Adam, R Reneland, M Andersson, et al.Pageof 5